Start-Ups Honored for Digital Health Solutions
The 2023 Health-i recognizes a trio of fledgling companies – CureVision, RadioReport and Semanux.
Your company is already operating in Germany and you would now like to export worldwide?
The 2023 Health-i recognizes a trio of fledgling companies – CureVision, RadioReport and Semanux.
Innovative start-ups are booming in Germany's attractive life sciences sector.
Therapeutics and autonomous driving, recycling and space junk, are all part of our regular survey of some of the most interesting developments in German research and development.
Japanese pharmaceuticals giant Takeda has put hundreds of millions of euros in recent years into its location in the southwestern German town of Singen to produce its anti-dengue-fever vaccine “Qdenga.”
The mood in German pharmaceuticals is bright, with companies looking to increase investment.
A quartet of young German companies have secured nine-figure financing rounds. Here’s our bimonthly round-up of some of the largest venture-capital deals in Germany.
Germany's research and development (R&D) landscape is second to none in the EU- whether it be practical, theoretical or industrial research. Here’s a round of some of the latest R&D breakthroughs “Made in Germany.”
As part of the Internationalization of Regions in Structural Transformation (ISW) program, Germany Trade & Invest is hosting an investor event for American Companies and Institutions about market opportunities in the healthcare industry.
This run-up webinar provided an overview of current and future developments in digital health in Germany. You learned how international companies utilize trade shows for successfully entering the German market.
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.